Back

Live Q&A and Adjourn.

31 August 2020 (13:30 - 13:45)
Organised by:
Congress Presentation Part of: Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl Cardiovascular Risk Assessment Open Access ESC Congress 2020

About the speakers

Photo
Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

Photo
Professor Borge Nordestgaard

Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Welcome and Introductions, Program Overview.
Professor P. Steg (Paris, FR)
Video
Presentation thumbnail
Hypertriglyceridaemia as a Causal Factor and Target for Therapy.
Professor B. Nordestgaard (Copenhagen, DK)
Video
Presentation thumbnail
Clinical Trial Evidence of Omega-3 Fatty Acids in ASCVD.
Professor P. Steg (Paris, FR)
Video
Presentation thumbnail
Practical Considerations on Using Omega-3 Fatty Acids to Prevent ASCVD.
Professor B. Nordestgaard (Copenhagen, DK)
Video

Access the full session

Session thumbnail
Clinical Update on Managing Hypertriglyceridaemia with Omega-3 Fatty Acid Icosapent Ethyl
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Q&A and meeting close
27 August 2023
thumbnail
Webinar
Current role of cardiovascular pharmacotherapy for arrhythmia management
9 December 2021
thumbnail
Webinar
Reducing risk in the post-MI patient
6 September 2023
thumbnail
Congress Presentation
Roundtable discussion - Q&A
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources